期刊文献+

选择性雌激素受体调节剂对MC3T3-E1细胞生长分化的调节 被引量:2

Selective estrogen receptor modulators stimulates growth and differentiation in MC3T3-E1 cells:involvement of ER and Wnt/β-catenin signals
下载PDF
导出
摘要 目的探讨选择性雌激素受体调节剂(selective estrogen receptor modulator,SERM)———雷洛昔芬对小鼠颅顶成骨细胞MC3T3-E1分化的调节及其机制。方法体外培养MC3T3-E1细胞,10-7mol/L的雷洛昔芬和雌激素受体拮抗剂ICI-182780刺激细胞,另设空白对照组,24、48、72 h后检测各指标。MTT法检测细胞增殖;微量酶标法检测细胞碱性磷酸酶(alkaline phosphatase,ALP)活性;实时荧光定量聚合酶链式反应(real time quantitative polymerase chain reaction,qRT-PCR)检测细胞内β-catenin,雌激素受体α、β(estrogen receptorα、β,ERα、ERβ)mRNA的表达。结果 MC3T3-E1细胞分别加入10-7mol/L的雷洛昔芬和ICI-182780后,相对于对照组,雷洛昔芬处理组的促细胞增殖作用较强,在24 h增殖率最高,达(55.93±10.88)%;ALP活性增加,在48 h活性增加率最高,为(30.881±5.614)%;β-catenin、ERα和ERβmRNA的表达均增高,有统计学意义(P<0.05)。ICI-182780组的促细胞增殖率、ALP活性降低;β-catenin、ERα和ERβmRNA的表达均降低,有统计学意义(P<0.05)。结论雷洛昔芬可能通过上调β-catenin、ERα和ERβmRNA的表达促进MC3T3-E1细胞的增殖分化,而ICI-182780则下调β-catenin、ERα和ERβmRNA的表达抑制MC3T3-E1细胞的增殖和分化。 Objective To investigate the regulation and mechanism of selective estrogen receptor modulator (SERM) raloxifene on the growth and differentiation in MC3T3-E1 cells in vitro. Methods MC3T3-E1 cells cultured in vitro were treated with raloxifene ( 10 ^-7 mol/L) and estrogen receptor antagonist ICI-182780 (10^-7 mol/L), respectively, and the MC3T3-E1 cells without treatment were set as control. The cell proliferation was observed by MTT assay, the activity of alkaline phosphatase (ALP) was measured by trace enzyme labeling method, and the expression of β-catenin, estrogen receptor (ER) α and ERβ were detected by qRT- PCR. Results As compared with those of the control group, the cell proliferation, ALP activity and mRNA expression of β-catenin, ERα and ERβ significantly increased in the raloxifene (10^-7 mol/L) group (P 〈 0. 05 ) and significantly decreased in the ICI-182780 group (P 〈 0. 05 ). The cell proliferation rate was highest (55.93 ±10.88)% at 24 h, and the ALP activity of increase was highest (30. 881 ±5. 614)% at 48 h. Conclusion Raloxifene can promote the proliferation and differentiation of MC3T3-E1 cells through up-regulating the mRNA expression of β-catenin, ERα and ERβ, while IC1-182780 can inhibit this process through down-regulating the mRNA expression of β-catenin, ERα and ERβ.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2012年第16期1617-1620,共4页 Journal of Third Military Medical University
基金 重庆市渝北区科委课题(渝北财教[2011]32号)~~
关键词 选择性雌激素受体调节剂 Β-CATENIN 雌激素受体 MC3T3-E1细胞 细胞分化 selective estrogen receptor modulator β-catenin estrogen receptor MC3T3-E1 cells cell differentiation
  • 相关文献

参考文献16

  • 1Notelovitz M. Estrogen therapy and osteoporosis: principles & practice [J]. Am J ned Sci, 1997, 313(1) : 2 -12.
  • 2Hansdottir H. Raloxifene for older women: a review of the literature [J]. Clin Interv Aging, 2008, 3(1) : 45 -50.
  • 3MacDonald B T, Tamai K, He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases [J]. Dev Cell, 2009, 17 ( 1 ) : 9 - 26.
  • 4Chen Y, Whetstone H C, Youn A, et al. Beta-catenin signaling pathway is crucial for bone morphogenetic protein 2 to induce new bone formation[J]. J Biol Chem, 2007, 282( 1 ) : 526 -533.
  • 5Gennari L, Merlotti D, Valleggi F, et al. Selective estrogen receptor modulators for postmenopausal osteoporosis: current state of development[J]. Drugs Aging, 2007, 24(5): 361 -379.
  • 6Recker R R, Mitlak B H, Ni X, et al. Long-term raloxifene for postmenopausal osteoporosis[J]. Curr Med Res Opin, 2011,27(9) : 1755 -1761.
  • 7Kanis J A, Johansson H, Oden A, et al. A meta-analysis of the efficacy of raloxifene on all clinical and vertebral fractures and its dependeneyonFRAX[J]. Bone, 2010, 47(4):729-735.
  • 8Olivier S, Fillet M, Malaise M, et al. Sodium nitroprusside-induced osteoblast apoptosis is mediated by long chain ceramide and is decreased by raloxifene[ J ]. Biochem Pharmacol, 2005, 69 (6) : 891 - 901.
  • 9Taranta A, Brama M, Teti A, et al. The selective estrogen receptor modulator raloxifene regulates osteoelast and osteoblast activity in vitro [J]. Bone, 2002, 30(2) : 368 -376.
  • 10Sliwinski L, Folwarczna J, Nowinska B, et al. A comparative study of the effects of genistein, estradiol and raloxifene on the murine skeletal system[ J]. Acta Biochim Pol, 2009, 56 (2) : 261 - 270.

同被引文献32

  • 1Lippuner K.The future of osteoporosis treatment——a research update.Swiss Med Wkly,2012;19(142):1-11.
  • 2Body JJ,Bergmann P,Boonen S,et al.Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis:a consensus document by the Belgian Bone Club.Osteoporos Int,2010;21(10):1657-1680.
  • 3Sliwiński L,Folwarczna J,Nowińska B,et al.A comparative study of the effects of genistein,estradiol and raloxifene on the murine skeletal system.Acta Biochim Pol,2009;56(2):261-270.
  • 4Pruitt LA.Weight-training effects on bone mineral density in early postmenopausal.J Bone Miner Res,1992;7(2):179-185.
  • 5Lidan Y,Sara T,Sean RC,et al.Bone cells grown on micropatterned surfaces are more sensitive to fluid shear stress.Cell Mol Bioeng,2008;1(3):182-188.
  • 6Smalt R,Mitchell FT,Howard RL,et al.Induction of NO and prostaglandin E2in osteoblasts by wall-shear stress but not mechanical strain.Am J Physiol,1997;273(4 Pt 1):E751-E758.
  • 7Shivaram GM,Kim CH,Batra NN,et al.Novel early response genes in osteoblasts exposed to dynamic fluid flow.Philos Transact A Math Phys Eng Sci,2010;368(1912):605-616.
  • 8Weinbaum S,Cowin SC,Zeng Y.A model for excitation of osteocytes by mechanical loading induced bone fluid shear stress.J Biomech,1994;27(3):339-360.
  • 9You J,Yellowley CE,Donahue HJ,et al.Substrate deformation levels associated with routine physical activity are less stimulatory to bone cells relative to loading-induced oscillatory fluid flow.J Biomech Eng,2000;122(4):387-393.
  • 10MacDonald B T,Tamai K,He X.Wnt/beta-catenin signaling:components,mechanisms,and diseases.Dev Cell,2009;17(1):9-26.

引证文献2

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部